
A man in his 70s is waiting for his appointment with the oncologist after being referred there by his family …
Novartis has discontinued phase III trials for its lung cancer candidate ASA404 after it once again failed to meet its …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

